The remarkable true story of the longest-held prisoner of war in American history, John Downey, Jr., a CIA officer captured in China during the Korean War and imprisoned for twenty-one years.John (Jack) Downey, Jr., was a new Yale graduate in the post-World War II years who, like other Yale grads, was recruited by the young CIA. He joined the Agency and was sent to Japan in 1952, during the Korean War. In a violation of protocol, he took part in an air drop that failed and was captured over China. His sources on the ground had been compromised, and his identity was known. Although he first tried to deny who he was, he eventually admitted the truth. But government policy forbade ever acknowledging the identity of spies, no matter the consequences. Washington invented a fictitious cover story and stood by it through four Administrations. As a result, Downey was imprisoned during the decades that Red China, as it was called, was considered by the US to be a hostile...

RetailIN THE ANTIDOTE, Barry Werth draws upon unprecedented inside reporting spanning more than two decades to provide a groundbreaking closeup of the upstart pharmaceutical company Vertex and the ferocious but indispensable world of Big Pharma that it inhabits. In 1989, the charismatic Joshua Boger left Merck, then America’s most admired business, to found a drug company that would challenge industry giants and transform health care. Werth described the company’s tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex’s bold endurance and eventual success. The $325 billion-a-year pharmaceutical business is America’s toughest and one of its most profitable. It’s riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine even after a molecule clears all the hurdles to get to human testing; to the multibillion-dollar cost of ramping up a successful product; to operating in the world’s most regulated industry, matched only by nuclear power. Werth captures the full scope of Vertex’s twentyfive- year drive to deliver breakthrough medicines. At a time when America struggles to maintain its innovative edge, The Antidote is a powerful inside look at one of the most intriguing and important business stories of recent decades.**